Avanos Medical (AVNS) Tax Provisions (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Tax Provisions data on file, last reported at $2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 19.35% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 140.94% YoY), and the FY2025 full-year result was $6.7 million, up 139.41% from the prior year.
• Tax Provisions was little changed at $2.5 million in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $6.2 million in Q3 2023 to a low of -$23.5 million in Q4 2024.
• A 5-year average of $152941.2 and a median of $1.9 million in 2022 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 788.89% in 2023 and sank 1019.05% in 2024, its largest moves.
• Tracing AVNS's Tax Provisions over 5 years: stood at $4.6 million in 2022, then slumped by 145.65% to -$2.1 million in 2023, then slumped by 1019.05% to -$23.5 million in 2024, then soared by 110.64% to $2.5 million in 2025, then changed by 0.0% to $2.5 million in 2026.
• Business Quant data shows AVNS's Tax Provisions at $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $200000.0 in Q3 2025.